118 related articles for article (PubMed ID: 5464164)
1. [Studies on anti-inflammatory agents. 8. Activity of 2-amino-3-ethoxycarbonyl-6-benzyl-4,5,6,7-tetrahydrothieno(2,3-c)pyridine (Y-3642) on central nervous system, respiration and cardiovascular system and the isolated organ].
Nakanishi M; Imamura H; Maruyama Y
Yakugaku Zasshi; 1970 Mar; 90(3):329-34. PubMed ID: 5464164
[No Abstract] [Full Text] [Related]
2. [Studies on anti-inflammatory agents. 3. Effect of 2-amino-3-ethoxycarbonyl-6-benzyl-4,5,6,7-tetrahydrothieno(2,3-c)pyridine (Y-3642) on pyretic reaction, vascular permeability and granuloma formation in experimental animals].
Nakanishi M; Imamura H; Maruyama Y
Yakugaku Zasshi; 1970 Mar; 90(3):284-90. PubMed ID: 5464157
[No Abstract] [Full Text] [Related]
3. [Studies on anti-inflammatory agents. IX. Effect of 2-amino-3-ethoxycarbonyl-6-benzyl-4,5,6,7-tetrahydrothieno[2,3-c]pyridine(Y-3642) on heat-induced hemolysis].
Nakanishi M; Imamura H; Goto K
Yakugaku Zasshi; 1970 May; 90(5):548-51. PubMed ID: 5464181
[No Abstract] [Full Text] [Related]
4. [Studies on anti-inflammatory agents. 18. Effect of 2-amino-3-ethoxycarbonyl-6-benzyl-4,5,6,7-tetrahydrothieno(2,3-c)pyridine (Y-3642) on the release of histamine in vitro and in vivo].
Nakanishi M; Imamura H; Goto K
Yakugaku Zasshi; 1971 Sep; 91(9):921-5. PubMed ID: 4108602
[No Abstract] [Full Text] [Related]
5. [Studies on anti-inflammatory agents. XI. Inhibitory effects of 2-aminno-3-ethoxycarbonyl-6-benzyl-4,5,6,7-tetrahydrothieno[2,3-c]pyridine (Y-3642) on platelet aggregation].
Nakanishi M; Imamura H; Goto K
Yakugaku Zasshi; 1970 May; 90(5):564-9. PubMed ID: 5464184
[No Abstract] [Full Text] [Related]
6. [Studies on anti-inflammatory agents. X. Stabilization of rat liver lysosome by 2-amino-3-ethoxycarbonyl-6-benzyl-4,5,6,7-tetrahydrothieno [2,3-c]pyridine (Y-3642)].
Nakanishi M; Imamura H; Goto K
Yakugaku Zasshi; 1970 May; 90(5):557-63. PubMed ID: 5464183
[No Abstract] [Full Text] [Related]
7. [Pharmacological studies of 2-(5H-[1]benzopyrano[2,3-b]pyridin-7-yl) propionic acid (Y-8004) (II). General pharmacological action].
Maruyama Y; Kadobe Y; Imamura H
Nihon Yakurigaku Zasshi; 1976 May; 72(4):403-16. PubMed ID: 987973
[TBL] [Abstract][Full Text] [Related]
8. [Pharmacological studies of a lipase GA-56 produced by Pseudomonas sp. 1. General pharmacological effects of GA-56].
Tamura S; Tsutsumi S; Nozaki S
Nihon Yakurigaku Zasshi; 1973 Jan; 69(1):177-89. PubMed ID: 4737518
[No Abstract] [Full Text] [Related]
9. [Studies on anti-inflammatory agents. II. Analgesic and anti-edematous activities of 2-amino-3-ethoxycarbonyl-6-benzyl-4,5,6, 7-tetrahydrothieno (2,3-c)pyridine (Y-3642)].
Nakanishi M; Imamura H; Maruyama Y
Yakugaku Zasshi; 1970 Mar; 90(3):277-83. PubMed ID: 5465051
[No Abstract] [Full Text] [Related]
10. [Pharmacology of a new potent analgesic].
Herrmann M; Steinbrecher W; Heldt W
Arzneimittelforschung; 1970 Aug; 20(8):977-83. PubMed ID: 5536518
[No Abstract] [Full Text] [Related]
11. [General pharmacological studies on cis-1-acetyl-4-[4-[[2-(2, 4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl] methoxy] phenyl] piperazine].
Nakamura J; Yamada K; Shuto K; Marumo H
Jpn J Antibiot; 1982 Jun; 35(6):1629-48. PubMed ID: 6290709
[No Abstract] [Full Text] [Related]
12. [Studies on anti-inflammatory agents. IV. On the appearance of physical dependence and analgesic activity of 2-amino-3-ethoxycarbonyl-6-benzyl-4,5,6-7-tetrahydrothieno(2,3-c)pyridine (Y-3642) by repeated administration].
Nakanishi M; Imamura H; Maruyama Y
Yakugaku Zasshi; 1970 Mar; 90(3):291-5. PubMed ID: 5464158
[No Abstract] [Full Text] [Related]
13. [Pharmacological studies of cefatrizine (S-640P) (author's transl)].
Matsuzaki M; Onodera K; Okazaki I; Nakajima A; Kishimoto K
Jpn J Antibiot; 1976 Jan; 29(1):107-21. PubMed ID: 1263334
[No Abstract] [Full Text] [Related]
14. [On the pharmacology of 2,3-dioxybenzoic acid].
Polukordas G; Repchite M; Skublitskene G
Farmakol Toksikol; 1966; 29(5):594-7. PubMed ID: 5995071
[No Abstract] [Full Text] [Related]
15. [Antiulcerogenic actions and other pharmacological properties of N-acetyl-L-glutamine aluminum complex (KW-110)].
Tanaka H; Shuto K; Ishii S; Orima H; Takahira H
Nihon Yakurigaku Zasshi; 1972 Sep; 68(5):602-17. PubMed ID: 4674711
[No Abstract] [Full Text] [Related]
16. [General pharmacology of aclacinomycin A (author's transl)].
Ohmori K; Hirano S; Hori S
Jpn J Antibiot; 1980 Feb; 33(2):192-213. PubMed ID: 6929361
[TBL] [Abstract][Full Text] [Related]
17. [General pharmacological studies on pepleomycin sulfate (NK 631) (author's transl)].
Ishii Y; Furuta Y; Adachi K; Fujii Y; Nakamura K; Itoh S; Saitoh K; Terada M; Watanabe H
Jpn J Antibiot; 1978 Dec; 31(12):910-21. PubMed ID: 83413
[TBL] [Abstract][Full Text] [Related]
18. Interference of some thiol derivatives with the pharmacological effects of arachidonic acid and slow reacting substance C and with the release of rabbit aorta contracting substances.
Vargaftig BB; Dao Hai N
Eur J Pharmacol; 1972 Apr; 18(1):43-55. PubMed ID: 4402307
[No Abstract] [Full Text] [Related]
19. [Pharmacological studies of 3',4'-dideoxykanamycin B].
Koeda T; Shibata U; Asaoka H; Kabata Y; Yamaki Y
Jpn J Antibiot; 1973 Feb; 26(1):28-39. PubMed ID: 4542395
[No Abstract] [Full Text] [Related]
20. Pharmacology of solanine.
Nishie K; Gumbmann MR; Keyl AC
Toxicol Appl Pharmacol; 1971 May; 19(1):81-92. PubMed ID: 4105761
[No Abstract] [Full Text] [Related]
[Next] [New Search]
